KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Current Assets (2016 - 2025)

Idexx Laboratories has reported Current Assets over the past 17 years, most recently at $1.4 billion for Q4 2025.

  • Quarterly results put Current Assets at $1.4 billion for Q4 2025, up 1.0% from a year ago — trailing twelve months through Dec 2025 was $1.4 billion (up 1.0% YoY), and the annual figure for FY2025 was $1.4 billion, up 1.0%.
  • Current Assets for Q4 2025 was $1.4 billion at Idexx Laboratories, down from $1.5 billion in the prior quarter.
  • Over the last five years, Current Assets for IDXX hit a ceiling of $1.5 billion in Q2 2024 and a floor of $938.0 million in Q3 2021.
  • Median Current Assets over the past 5 years was $1.2 billion (2023), compared with a mean of $1.2 billion.
  • Biggest five-year swings in Current Assets: skyrocketed 52.19% in 2021 and later dropped 12.27% in 2025.
  • Idexx Laboratories' Current Assets stood at $955.7 million in 2021, then grew by 15.26% to $1.1 billion in 2022, then skyrocketed by 35.75% to $1.5 billion in 2023, then fell by 6.38% to $1.4 billion in 2024, then increased by 1.0% to $1.4 billion in 2025.
  • The last three reported values for Current Assets were $1.4 billion (Q4 2025), $1.5 billion (Q3 2025), and $1.4 billion (Q2 2025) per Business Quant data.